MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,124 | -100.0% | 400,000 | -30.4% | 1.21% | -56.8% |
| Q3 2022 | $40,158,000 | +99.4% | 575,000 | +91.7% | 2.81% | +84.3% |
| Q2 2022 | $20,139,000 | +389.9% | 300,000 | +500.0% | 1.52% | +382.0% |
| Q1 2022 | $4,111,000 | -62.6% | 50,000 | -33.3% | 0.32% | -51.7% |
| Q4 2021 | $11,002,000 | -48.2% | 75,000 | -37.5% | 0.65% | -24.2% |
| Q3 2021 | $21,229,000 | -24.9% | 120,000 | -31.4% | 0.86% | -10.1% |
| Q2 2021 | $28,268,000 | -40.0% | 175,000 | -36.4% | 0.96% | -8.5% |
| Q1 2021 | $47,108,000 | -34.0% | 275,000 | -15.4% | 1.05% | -38.3% |
| Q4 2020 | $71,383,000 | +56.3% | 325,000 | +18.2% | 1.70% | -3.2% |
| Q3 2020 | $45,664,000 | -20.0% | 275,000 | -45.0% | 1.76% | -19.4% |
| Q2 2020 | $57,085,000 | -45.0% | 500,000 | -63.0% | 2.18% | -54.8% |
| Q1 2020 | $103,775,000 | -54.8% | 1,350,000 | -24.3% | 4.82% | -47.4% |
| Q4 2019 | $229,679,000 | +25.4% | 1,782,392 | -24.2% | 9.16% | -17.8% |
| Q3 2019 | $183,089,000 | +36.7% | 2,350,000 | +80.8% | 11.14% | +44.9% |
| Q2 2019 | $133,900,000 | +69.9% | 1,300,000 | +20.9% | 7.69% | +44.4% |
| Q1 2019 | $78,798,000 | +6.0% | 1,075,000 | -38.6% | 5.33% | -11.7% |
| Q4 2018 | $74,307,000 | -12.8% | 1,751,699 | -3.2% | 6.03% | +8.9% |
| Q3 2018 | $85,251,000 | -9.9% | 1,810,000 | -5.6% | 5.54% | -20.8% |
| Q2 2018 | $94,575,000 | +60.6% | 1,918,350 | 0.0% | 7.00% | +59.4% |
| Q1 2018 | $58,893,000 | +162.0% | 1,918,350 | +55.8% | 4.39% | +86.6% |
| Q4 2017 | $22,475,000 | +92.1% | 1,231,522 | +23.2% | 2.35% | +13.9% |
| Q3 2017 | $11,700,000 | +10.4% | 1,000,000 | +101.9% | 2.07% | +29.4% |
| Q1 2016 | $10,601,000 | -32.3% | 495,356 | 0.0% | 1.60% | -14.7% |
| Q4 2015 | $15,653,000 | +78.3% | 495,356 | +94.3% | 1.87% | +33.6% |
| Q3 2015 | $8,777,000 | – | 255,000 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |